Approximately 9.5 million people globally live with type 1 diabetes, a chronic autoimmune disease where T cells from the body ...

The landmark agreement would allow the west African nation to enter the booming insulin industry as diabetes rates surge ...

Insulin-producing cells can be genetically modified to hide from the immune system. People with type 1 diabetes must constantly rely on insulin injections or pumps, usually for the rest of their life ...

Regenerative Medical Solutions (RMS), a Wisconsin-based biotech company, has been awarded a peer-reviewed National Institutes ...

At EASD 2025, investigators reported one-year outcomes from a study of zimislecel (VX-880), an allogeneic, stem cell-derived islet therapy.

Researchers writing in The Lancet review breakthroughs in type 1 diabetes treatment, from immunotherapies that delay onset to ...

Researchers at WashU Medicine have discovered that certain immune cells in the pancreas, called macrophages, can protect insulin-producing cells and ...

A nonprofit in Cambridge is aiming to make insulin more accessible by selling vials of the drug at a fraction of the cost.

Nigeria is poised to host the continent’s first local insulin production facility, even as its aviation regulators move to ...